MC-DOXHZN is primarily utilized in the field of medical research, particularly in the development of targeted cancer therapies. Its application is focused on enhancing the delivery of chemotherapeutic agents to cancer cells while minimizing damage to healthy tissues. This compound is often employed in the formulation of drug delivery systems, such as nanoparticles or liposomes, which are designed to improve the bioavailability and efficacy of anticancer drugs. Additionally, MC-DOXHZN is studied for its potential to overcome drug resistance in certain types of cancers, making it a valuable component in the advancement of personalized medicine and innovative treatment strategies. Its role in improving therapeutic outcomes and reducing side effects highlights its significance in oncology research.